ARTICLE | Company News
Seattle Genetics, ICOS in monoclonal antibody deal
August 14, 2001 7:00 AM UTC
Icos will provide process development, scale-up and GMP manufacturing for the monoclonal antibody component of SGEN's SGN-15 antibody-drug conjugate. SGN-15, a monoclonal antibody (MAb) chemically lin...